January 2017 Current Abstracts

The following is a monthly list of selected journal articles and reports on tobacco topics. Please note that this list is not all-inclusive. We try to choose titles of interest to our tobacco control network, but we realize that there are many relevant articles that are not listed.

Archived abstracts are available.

Full text is available where indicated, otherwise, a fee may be required.

Canadian flag denotes Canadian Content The Canadian flag denotes a Canadian author and/or Canadian content.

freeicon The free icon denotes that a publication is free to the public (free full text/PDF)

Hot Topics

The WHO and the US National Cancer Institute released a major report on the economics of tobacco. The report concluded that tobacco cost more than $1 trillion dollars US annually worldwide and that 6 million people a year die annually from tobacco use, mostly in low and middle income countries.


U.S. National Cancer Institute and World Health Organization. The Economics of Tobacco and Tobacco Control. National Cancer Institute Tobacco Control Monograph 21. NIH Publication No. 16-CA-8029A. Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute; and Geneva, CH: World Health Organization; 2016. freeicon


Smoking Cessation—Cancer Patients
Klemp I, Steffenssen M, Bakholdt V, Thygesen T, Sørensen JA. Counseling is effective for smoking cessation in head and neck cancer patients—A systematic review and meta-analysis. Journal of Oral and Maxillofacial Surgery 2016 Aug;74(8):1687-94.
Smoking Cessation—Cardiovascular Patients
Suissa K, Larivière J, Eisenberg MJ, Eberg M, Gore GC, Grad R, et al. Efficacy and safety of smoking cessation interventions in patients with cardiovascular disease. Circulation: Cardiovascular Quality and Outcomes 2017;10(1).

Recent Work by Canadian Researchers Canadian flag denotes Canadian Content

Levy DT, Borland R, Fong GT, Villanti AC, Niaura R, Meza R, et al. Developing consistent and transparent models of e-cigarette use: reply to Glantz and Soneji et al. Nicotine & Tobacco Research 2017 Feb;19(2):268-70.
Dewhirst T, Lee WB, Fong GT, Ling PM. Exporting an inherently harmful product: the marketing of Virginia Slims cigarettes in the United States, Japan, and Korea. Journal of Business Ethics 2016 Nov;139(1):161-81.
Poirier AE, Grundy A, Khandwala F, Tamminen S, Friedenreich CM, Brenner DR. Cancer incidence attributable to tobacco in Alberta, Canada, in 2012. CMAJ Open 2016 Oct ;4(4):E578-87. freeicon
Smoking—Cancer Survivors
Naik H, Qiu X, Brown MC, Eng L, Pringle D, Mahler M, et al. Socioeconomic status and lifestyle behaviours in cancer survivors: smoking and physical activity. Current Oncology 2016 Dec;23(6):e546-55. freeicon
Smoking—Multiple Sclerosis
Briggs FB, Gunzler DD, Ontaneda D, Marrie RA. Smokers with MS have greater decrements in quality of life and disability than non-smokers. Multiple Sclerosis Journal 2017 Jan;135245851668516.
Smoking—Venous Thromboembolism
Anand SS. Smoking: A Dual Pathogen for Arterial and Venous Thrombosis. Circulation 2017 Jan;135(1):17-20.
Smoking Cessation—Nicotine Replacement
Kushnir V, Sproule BA, Cunningham JA. Mailed distribution of free nicotine patches without behavioral support: Predictors of use and cessation. Addictive Behaviors 2017 Apr;67:73-8.
Smoking Cessation—Pregnancy
Bottorff JL, Oliffe JL, Sarbit G, Caperchione C, Clark M, Anand A, et al. Assessing the feasibility, acceptability and potential effectiveness of an integrated approach to smoking cessation for new and expectant fathers: The Dads in Gear study protocol. Contemporary Clinical Trials 2017 Jan [Epub ahead of print].
Smoking Cessation—Varenicline
Rigotti NA, Pipe AL, Benowitz NL, Arteaga C, Garza D, Tonstad S. Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Cardiovascular Disease: A Randomized Trial. Circulation 2010 Jan;121(2):221-9. freeicon